Home › Heart Failure › North Carolina › Greensboro
Heart Failure clinical trials in Greensboro, NC
6 studies for Heart Failure are looking for participants at sites in and around Greensboro (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RecruitingPhase 3
- Medication Management, LLC, Greensboro
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
RecruitingPhase 3
- Research Site, Greensboro
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RecruitingPhase 3
- Moses H. Cone Memorial Hospital Operating Corporation d/b/a Cone Health, Greensboro
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
RecruitingPhase 2
- Local Institution - 159, Greensboro
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RecruitingObservational studyHealthy volunteers welcome
- Moses H. Cone Memorial Hospital, Greensboro
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
RecruitingObservational study
- Moses H. Cone Memorial Hospital, Greensboro
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA44 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Durham, NC26 studies
- St. Louis, MO26 studies
- Atlanta, GA25 studies
- Kansas City, MO25 studies
Other studies in Greensboro
- Overweight12 studies
- Obesity12 studies
- Type 2 Diabetes6 studies
- Breast Cancer5 studies
- Cardiovascular Disease5 studies
- HIV4 studies
- Stroke4 studies
- Interstitial Lung Diseases4 studies
- Heart Attack4 studies
- Lung Cancer3 studies
- Idiopathic Pulmonary Fibrosis3 studies
- Atherosclerosis3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.